Literature DB >> 4118816

Bioavailability of digoxin.

A J Jounela, A Sothmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4118816     DOI： 10.1016/s0140-6736(73)90032-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

Authors:  Michael A Fischer; Jerry Avorn
Journal:  Health Serv Res       Date:  2003-08       Impact factor: 3.402

2.  [Isomerisation and bioavailability of beta- and alpha-acetyldigoxin (author's transl)].

Authors:  N Rietbrock; H F Vöhringer; J Kuhlmann; K Maertin
Journal:  Klin Wochenschr       Date:  1977-07-01

Review 3.  Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.

Authors:  O I Corrigan; R F Timoney
Journal:  Ir J Med Sci       Date:  1974-07       Impact factor: 1.568

4.  Zero plasma digoxin levels in patients on oral digoxin therapy.

Authors:  P F Binnion
Journal:  Ir J Med Sci       Date:  1974-11       Impact factor: 1.568

Review 5.  Bioavailability of drugs: the digoxin dilemma.

Authors:  D J Greenblatt; T W Smith; J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.